Lodelcizumab (LGT 209) is a monoclonal antibody targeting the preprotein convertase Bacillus subtilis protease Kexin-9 (PCSK9) and is used to study hypercholesterolemia.
Purity:
98.70%
CAS Number:
[1355338-54-3]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted